OpenAlex
PricingAboutJobs
Log inGet started
Work

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and Morphologic Changes-A 96-Week Analysis

HTML

Year: 2006
Type: article
Study design: Clinical Trial
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI: 10.1097/01.qai.0000245886.51262.67
Authors: Anton L Pozniak, Joel E Gallant, Edwin DeJesus, Jose R Arribas, Brian Gazzard, Rafael E Campo, Shan-Shan Chen, Damian McColl, Jeffrey Enejosa, John J Toole, Andrew K Cheng
Institutions: Bristol-Myers Squibb (United States), Chelsea and Westminster Hospital, Johns Hopkins University, Johns Hopkins Medicine, Orlando Immunology Center, Hospital Universitario La Paz, Universidad Autónoma de Madrid, University of Miami, Gilead Sciences (United States)
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: tenofovir disoproxil fumarate, emtricitabine, efavirenz, zidovudine/lamivudine, viral suppression, CD4 count increase, K65R mutation, lipodystrophy, long-term treatment outcomes
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2016257631
FWCI: 16.72
Cites: 14
Cited by: 257
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms